Webinar presentations: Genetics of pulmonary arterial hypertension: What we can learn by studying children with and without congenital heart disease, Wendy Chung, Therapeutic options in advanced PVD: Potts shunt versus lung transplantation, Mark Grady, Stem cells and Regenerative Medicine for Neonatal Lung Disease: implications for COPD, Bernard Thebaud, Assessment of operability in patients with congenital heart disease and PAH: Fallacies and pitfalls, Erika B. Rosenzweig, The impact of chronic pulmonary hypertension on ventricular function in extremely premature infants, Gabriela de Carvalho Nunes, Improving guidance for the correctability of congenital cardiovascular shunts with increased pulmonary vascular resistance, Ronald Day

Webinar presentations: Cancer induced PH: Embolism as a major inducer, Timothy Morris, Cancer induced PH: Microenvironmental cancer niche as a major inducer, Rajkumar Savai, Cancer therapies induced PH, Frédéric Perros, Cancer related signalling mechanisms underlying PH development, Olivier Boucherat, FOXO3: A new potential therapeutic target in pulmonary arterial hypertension, Yann Grobs, Non-invasive surrogate markers of PH are associated with poor survival in lung cancer patients, Michael Cekay